Professors Anna Schwedenman¹ and Sarfaraz Niazi² awarded a $2 Million FDA grant to create novel analytical methods to reduce the cost of developing biosimilars

CHICAGO, Nov. 22, 2022 /PRNewswire/ -- To reduce the cost of development of the approval of biosimilars, the FDA is encouraging the introduction of novel analytical methods to establish biosimilarity,

Related Keywords

Michigan ,United States ,University Of Illinois ,Illinois ,Chicago ,J Clin Pharm ,Us Senate ,College Of Pharmacy ,Us Congress ,University Of Michigan ,Analytical Characterization ,Biosimilar Products ,Post Translational Modifications ,Professors Schwendeman ,Waiving Clinical Efficacy Testing ,Drug Des Devel ,Clin Pharm ,Sarfaraz Niazi Convinces ,